Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

No, this podcast does not typically feature guests.

ESO Voice of Stroke

Claim This Podcast

by European Stroke Organisation

6 episodes

Updated Daily

Accepts GuestsHas SponsorsLocation 🇪🇺

Podcast Overview

Welcome to Voice of Stroke, brought to you by the European Stroke Organisation. Your fast, reliable update on the science driving stroke care forward. Each month, we spotlight key papers from the world's leading journals and discuss how it can inform and refine clinical practice. From breakthrough randomised controlled trials to cross-disciplinary insights, Voice of Stroke brings you concise, evidence-based takeaways — straight from the front lines of research. Stay informed. Stay inspired. Listen to Voice of Stroke on Spotify, Apple, or wherever you get your podcasts.

Language

🇺🇲

Publishing Since

2/9/2026

Visit Website View on Apple Podcasts RSS Feed

2 verified contact emails on file for ESO Voice of Stroke

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

June 23, 2026

Blood Pressure Control: Which Patients May Benefit Most From Specific Strategies?

How should clinicians think about hypertension in 2026? In this episode of Voice of Stroke, we explore recent evidence addressing one of the most important questions in vascular prevention: not simply whether to lower blood pressure, but which treatments work best, who should be treated, and how hypertension-related vascular disease may influence stroke mechanisms and secondary prevention. This episode discusses:<span style= "font-style: normal; font-variant: normal; font-size-adjust: none; font-language-override: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman';"> <ul> <li class="MsoNormal" style="font-size: 12pt;">Meta-analyses evaluating the efficacy and tolerability of antihypertensive drugs and combinations</li> <li class="MsoNormal" style="font-size: 12pt;">Blood pressure lowering in isolated diastolic hypertension</li> <li class="MsoNormal" style="font-size: 12pt;">An exploratory analysis of the ARCADIA trial examining high-risk hypertension features and recurrent stroke prevention</li> </ul> Featuring discussion of recent studies published in The Lancet, JAMA, European Heart Journal and JAMA Neurology. Written by Voice of Stroke Podcast Editor-In-Chief Linxin Li and Co-Editor Maria Magdalena Gabriel. Read the full transcript <a style= "mso-comment-reference: NS_1; mso-comment-date: 20260618T0855;" href= "https://eso-stroke.org/wp-content/uploads/ESO-Podcast_EP5_Transcript.pdf" target="_blank" rel="noopener">here.</a> <h3>References</h3> <ul> <li>Ridha M et al. Hypertension With High-Risk Features in Cryptogenic Stroke: An Exploratory Analysis of the ARCADIA Randomized Clinical Trial. JAMA Neurology. 2026.</li> <li>Bidel Z et al. Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis. European Heart Journal. 2026.</li> <li>Wang N et al. Blood pressure-lowering efficacy of antihypertensive drugs and their combinations. The Lancet. 2025.</li> <li>Wang N et al. Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations. JAMA. 2026.</li> <li>Blood Pressure Treatment Efficacy Calculator: <a href="https://www.bpmodel.org/blood-pressure-treatment-efficacy-calculator/">https://www.bpmodel.org/blood-pressure-treatment-efficacy-calculator/</a></li> </ul> <div style="mso-element: comment-list;">  <div style="mso-element: comment;"> <div id="_com_1" class="msocomtxt"></div> </div> </div>

May 28, 2026

Intracerebral Haemorrhage – From Blood Pressure Control to Secondary Brain Injury

In this episode of Voice of Stroke we explore major recent advances in intracerebral haemorrhage research. This episode discusses: <ul type="disc"> <li class="MsoNormal" style= "line-height: normal; font-size: 12pt;">The TRIDENT trial and long-term blood pressure lowering after ICH</li> <li class="MsoNormal" style= "line-height: normal; font-size: 12pt;"> Perihaematomal oedema growth as a biomarker of secondary brain injury</li> <li class="MsoNormal" style= "line-height: normal; font-size: 12pt;"> Translational neuroimmunology and inflammatory signalling after haemorrhage</li> <li class="MsoNormal" style= "line-height: normal; font-size: 12pt;">Highlights from the ESO ICH Academy Meeting in Maastricht</li> </ul> Featuring discussion of recent publications in the New England Journal of Medicine, Stroke, and Annals of Neurology. Written by Voice of Stroke Podcast Editor-in-Chief Linxin Li and Co-editor Annemijn Algra. Listen on Spotify, Apple Podcasts, and via the European Stroke Organisation website. Read the full transcript here: <a href= "https://eso-stroke.org/wp-content/uploads/ESO-Podcast-EP4_Transcript.pdf"> https://eso-stroke.org/wp-content/uploads/ESO-Podcast-EP4_Transcript.pdf</a>   References 1. The Trident Research Group. Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage. N Engl J Med. 2026; 394: 1571-1582. doi: 10.1056/NEJMoa2515043. https://www.nejm.org/doi/full/10.1056/NEJMoa2515043 2. Samarasekera N et al. Perihematomal Edema and Functional Outcome After Intracerebral Hemorrhage: A Meta-Analysis of Individual Participant Data. Stroke 2026; 57: 1310-1324. doi: 10.1161/STROKEAHA.125.053991. https://www.ahajournals.org/doi/epdf/10.1161/STROKEAHA.125.053991 3. Parry-Jones A et al. Hematoma Interleukin-1 ReceptorAntagonist Concentrations PredictLong-Term Outcome in AcuteHuman Intracerebral Hemorrhage. Ann Neurol 2026; 00: 1-16. doi: 10.1002/ana.78237. https://onlinelibrary.wiley.com/doi/epdf/10.1002/ana.78237 4. ICH Academy Meeting: https://eso-stroke.org/resources/eso-ich-academy-meeting-iam/

April 23, 2026

Atrial Fibrillation and Stroke Prevention – What's New?

In this episode of Voice of Stroke, we explore the latest evidence shaping stroke prevention in atrial fibrillation (AF) – a condition responsible for up to a quarter of all ischaemic strokes. This episode examines emerging strategies and unresolved questions in AF management, including: <ul type="disc"> <li class="MsoNormal" style= "mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l2 level1 lfo1; tab-stops: list 36.0pt;"> Whether left atrial appendage closure (LAAC) can replace anticoagulation in patients eligible for oral therapy</li> <li class="MsoNormal" style= "mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l2 level1 lfo1; tab-stops: list 36.0pt;"> The role of catheter ablation in reducing recurrent stroke risk after AF-related stroke</li> <li class="MsoNormal" style= "mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l2 level1 lfo1; tab-stops: list 36.0pt;"> New population data on blood pressure control and stroke risk, particularly in younger AF patients</li> </ul> <h3>Key insights:</h3> <ul type="disc"> <li class="MsoNormal" style= "mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l1 level1 lfo2; tab-stops: list 36.0pt;"> Anticoagulation remains the cornerstone of stroke prevention, but limitations persist</li> <li class="MsoNormal" style= "mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l1 level1 lfo2; tab-stops: list 36.0pt;"> LAAC may reduce bleeding risk but does not yet clearly outperform anticoagulation in eligible patients</li> <li class="MsoNormal" style= "mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l1 level1 lfo2; tab-stops: list 36.0pt;"> Catheter ablation did not reduce recurrent stroke risk in current trial evidence</li> <li class="MsoNormal" style= "mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l1 level1 lfo2; tab-stops: list 36.0pt;"> Blood pressure is a critical—and potentially under-recognised—driver of stroke risk in AF, especially in younger populations</li> </ul> Together, these findings refine how we approach AF stroke prevention, balancing procedural interventions, pharmacological therapy, and risk factor management. This episode was written by Voice of Stroke Podcast editor Umberto Pensato and Editor-in-Chief Linxin Li. Read the full transcript here: <a href= "https://eso-stroke.org/wp-content/uploads/ESO-Podcast-EP3_Transcript.pdf"> https://eso-stroke.org/wp-content/uploads/ESO-Podcast-EP3_Transcript.pdf</a>   ----- References Landmesser U et al. Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation. N Endl J Med. 2026; 394: 1270-1280. doi: 10.1056/NEJMoa2513310. <a href= "https://www.nejm.org/doi/full/10.1056/NEJMoa2513310">https://www.nejm.org/doi/full/10.1056/NEJMoa2513310</a> Doshi SK et al. Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation. N Engl J Med. 2026 Mar 28. doi: 10.1056/NEJMoa2517213 <a href= "https://www.nejm.org/doi/full/10.1056/NEJMoa2517213">https://www.nejm.org/doi/full/10.1056/NEJMoa2517213</a> Kimura K et al. Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation: The STABLED Randomized Clinical Trial. JAMA Neurol. 2026 Mar 2:e260155. doi: 10.1001/jamaneurol.2026.0155. <a href= "https://jamanetwork.com/journals/jamaneurology/fullarticle/2845745"> https://jamanetwork.com/journals/jamaneurology/fullarticle/2845745</a> Jeong MH et al. Impact of blood pressure on the risk of stroke and all-cause mortality in patients with atrial fibrillation across different age groups: a nationwide population-based study. Heart Rhythm. 2026 Mar 24:S1547-5271(26)02172-7. doi: 10.1016/j.hrthm.2026.03.1917. <a href= "https://www.heartrhythmjournal.com/article/S1547-5271(26)02172-7/fulltext"> https://www.heartrhythmjournal.com/article/S1547-5271(26)02172-7/fulltext</a>

6 total episodes available

Similar Podcasts

Discover related shows you might enjoy

Neurology® Podcast

American Academy of Neurology

Continuum Audio

American Academy of Neurology

Practical Neurology Podcast

BMJ Group

Stroke Alert

Negar Asdaghi, MD, MSc, FRCPC, FAHA

NEJM This Week

NEJM Group

TED Talks Daily

TED

The Rest Is Politics

Goalhanger

Neurology Minute

American Academy of Neurology

Americast

BBC News

Elis James and John Robins

Significant Productions

Football Weekly

The Guardian

Leading

Goalhanger

6 Minute English

BBC Radio

The Rest Is History

Goalhanger

Neurology Today in 5

American Academy of Neurology

Deep-dive analytics for ESO Voice of Stroke

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is ESO Voice of Stroke?: Welcome to Voice of Stroke, brought to you by the European Stroke Organisation. Your fast, reliable update on the science driving stroke care forward.

Each month, we spotlight key papers from the world's leading journals and discuss how it can inform and refine clinical practice.

From breakthrough randomised controlled trials to cross-disciplinary insights, Voice of Stroke brings you concise, evidence-based takeaways — straight from the front lines of research.

Stay informed. Stay inspired. Listen to Voice of Stroke on Spotify, Apple, or wherever you get your podcasts.
How often does this podcast release new episodes?: This podcast updates daily.
Where can I listen to this podcast?: This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: No, this podcast does not typically feature guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.